Giovanni Grignani

37PUBLICATIONS
161CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillancePredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Aug 12, 2025
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).

Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé

|Jan 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano

|Dec 02, 2024
Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies.

Chiara Colombo, Stefanie Hakkesteegt, Axel Le Cesne

|Sep 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

David S Moura, Jesus M Lopez-Marti, Iva Benesova

Pageof 7

Frequent Collaborators

8 joint publications

Silvia Stacchiotti

8 joint publications

Emanuela Palmerini

7 joint publications

Javier Martin-Broto

6 joint publications

Jean-Yves Blay